ENSG00000184634 |
|
Fibroadenoma |
translational_product_function_variant |
53.44% (334/625) |
2 entries |
ENSG00000184634 |
|
leiomyoma |
sequence_alteration |
51.81% (1915/3696) |
33 entries |
ENSG00000184634 |
|
Fibroadenoma |
conservative_inframe_deletion |
53.44% (334/625) |
13 entries |
ENSG00000184634 |
|
breast phyllodes tumor |
conservative_inframe_deletion |
54.58% (501/918) |
16 entries |
ENSG00000184634 |
|
breast phyllodes tumor |
frameshift_variant |
54.58% (501/918) |
4 entries |
ENSG00000184634 |
|
Fibroadenoma |
frameshift_variant |
53.44% (334/625) |
5 entries |
ENSG00000184634 |
|
leiomyoma |
missense_variant |
51.81% (1915/3696) |
31 entries |
ENSG00000184634 |
|
breast phyllodes tumor |
sequence_alteration |
54.58% (501/918) |
17 entries |
ENSG00000184634 |
|
Fibroadenoma |
sequence_alteration |
53.44% (334/625) |
14 entries |
ENSG00000184634 |
|
leiomyoma |
frameshift_variant |
51.81% (1915/3696) |
2 entries |
ENSG00000184634 |
|
breast phyllodes tumor |
missense_variant |
54.58% (501/918) |
17 entries |
ENSG00000184634 |
|
leiomyoma |
amino_acid_insertion |
51.81% (1915/3696) |
5 entries |
ENSG00000184634 |
|
Fibroadenoma |
missense_variant |
53.44% (334/625) |
16 entries |
ENSG00000184634 |
|
leiomyoma |
stop_gained |
51.81% (1915/3696) |
1 entry |
ENSG00000184634 |
|
breast phyllodes tumor |
amino_acid_insertion |
54.58% (501/918) |
1 entry |
ENSG00000184634 |
|
leiomyoma |
conservative_inframe_deletion |
51.81% (1915/3696) |
27 entries |
ENSG00000184634 |
|
Breast Carcinoma by Gene Expression Profile |
conservative_inframe_deletion |
2.588% (33/1275) |
1 entry |
ENSG00000184634 |
|
diffuse large B-cell lymphoma |
missense_variant |
1.081% (4/370) |
1 entry |
ENSG00000184634 |
|
Endometrial Endometrioid Adenocarcinoma |
missense_variant |
6.769% (44/650) |
2 entries |
ENSG00000184634 |
|
prostate adenocarcinoma |
missense_variant |
1.408% (35/2486) |
4 entries |
ENSG00000184634 |
|
colorectal adenocarcinoma |
amino_acid_insertion |
3.268% (73/2234) |
2 entries |
ENSG00000184634 |
|
cervical squamous cell carcinoma |
missense_variant |
2.769% (9/325) |
1 entry |
ENSG00000184634 |
|
adrenal cortex carcinoma |
missense_variant |
2.632% (7/266) |
2 entries |
ENSG00000184634 |
|
nasopharyngeal squamous cell carcinoma |
missense_variant |
0.6494% (2/308) |
1 entry |
ENSG00000184634 |
|
lobular breast carcinoma |
missense_variant |
2.5% (7/280) |
1 entry |
ENSG00000184634 |
|
endometrial stromal sarcoma |
sequence_alteration |
10.0% (3/30) |
1 entry |
ENSG00000184634 |
|
hepatocellular carcinoma |
missense_variant |
1.012% (10/988) |
1 entry |
ENSG00000184634 |
|
brain glioblastoma |
sequence_alteration |
1.896% (23/1213) |
2 entries |
ENSG00000184634 |
|
chronic lymphocytic leukemia |
missense_variant |
3.575% (70/1958) |
6 entries |
ENSG00000184634 |
|
colon adenocarcinoma |
conservative_inframe_deletion |
5.594% (72/1287) |
4 entries |
ENSG00000184634 |
|
breast carcinoma |
sequence_alteration |
2.267% (38/1676) |
1 entry |
ENSG00000184634 |
|
breast ductal adenocarcinoma |
missense_variant |
2.232% (41/1837) |
5 entries |
ENSG00000184634 |
|
clear cell renal carcinoma |
missense_variant |
1.047% (16/1528) |
5 entries |
ENSG00000184634 |
|
melanoma |
sequence_alteration |
11.64% (17/146) |
2 entries |
ENSG00000184634 |
|
Disseminated Peritoneal Leiomyomatosis |
conservative_inframe_deletion |
100.0% (8/8) |
1 entry |
ENSG00000184634 |
|
Gallbladder Adenocarcinoma |
sequence_alteration |
1.818% (3/165) |
2 entries |
ENSG00000184634 |
|
brain glioblastoma |
stop_gained |
1.896% (23/1213) |
2 entries |
ENSG00000184634 |
|
bile duct adenocarcinoma |
missense_variant |
1.535% (6/391) |
2 entries |
ENSG00000184634 |
|
Breast Carcinoma by Gene Expression Profile |
stop_gained |
2.588% (33/1275) |
1 entry |
ENSG00000184634 |
|
leiomyosarcoma |
sequence_alteration |
8.062% (57/707) |
12 entries |
ENSG00000184634 |
|
T-cell acute lymphoblastic leukemia |
stop_gained |
2.532% (16/632) |
2 entries |
ENSG00000184634 |
|
leiomyosarcoma |
amino_acid_insertion |
8.062% (57/707) |
2 entries |
ENSG00000184634 |
|
Disseminated Peritoneal Leiomyomatosis |
missense_variant |
100.0% (8/8) |
2 entries |
ENSG00000184634 |
|
lung adenocarcinoma |
sequence_alteration |
3.743% (95/2538) |
2 entries |
ENSG00000184634 |
|
Disseminated Peritoneal Leiomyomatosis |
sequence_alteration |
100.0% (8/8) |
2 entries |
ENSG00000184634 |
|
breast ductal adenocarcinoma |
stop_gained |
2.232% (41/1837) |
2 entries |
ENSG00000184634 |
|
cecum adenocarcinoma |
sequence_alteration |
6.415% (17/265) |
2 entries |
ENSG00000184634 |
|
bladder carcinoma |
missense_variant |
3.209% (18/561) |
1 entry |
ENSG00000184634 |
|
anaplastic astrocytoma |
missense_variant |
1.515% (2/132) |
2 entries |
ENSG00000184634 |
|
bile duct adenocarcinoma |
sequence_alteration |
1.535% (6/391) |
1 entry |
ENSG00000184634 |
|
skin melanoma |
sequence_alteration |
3.27% (38/1162) |
1 entry |
ENSG00000184634 |
|
colon adenocarcinoma |
frameshift_variant |
5.594% (72/1287) |
2 entries |
ENSG00000184634 |
|
neoplasm of mature B-cells |
missense_variant |
3.279% (2/61) |
1 entry |
ENSG00000184634 |
|
gastric intestinal type adenocarcinoma |
missense_variant |
3.529% (3/85) |
1 entry |
ENSG00000184634 |
|
kidney Wilms tumor |
missense_variant |
0.9091% (3/330) |
2 entries |
ENSG00000184634 |
|
colorectal adenocarcinoma |
conservative_inframe_deletion |
3.268% (73/2234) |
2 entries |
ENSG00000184634 |
|
leiomyosarcoma |
missense_variant |
8.062% (57/707) |
12 entries |
ENSG00000184634 |
|
esophageal squamous cell carcinoma |
missense_variant |
1.46% (10/685) |
6 entries |
ENSG00000184634 |
|
small cell lung carcinoma |
sequence_alteration |
3.386% (15/443) |
2 entries |
ENSG00000184634 |
|
breast carcinoma |
missense_variant |
2.267% (38/1676) |
6 entries |
ENSG00000184634 |
|
gastric adenocarcinoma |
sequence_alteration |
4.625% (37/800) |
2 entries |
ENSG00000184634 |
|
T-cell acute lymphoblastic leukemia |
sequence_alteration |
2.532% (16/632) |
2 entries |
ENSG00000184634 |
|
skin melanoma |
stop_gained |
3.27% (38/1162) |
2 entries |
ENSG00000184634 |
|
breast ductal adenocarcinoma |
frameshift_variant |
2.232% (41/1837) |
1 entry |
ENSG00000184634 |
|
lung adenocarcinoma |
frameshift_variant |
3.743% (95/2538) |
1 entry |
ENSG00000184634 |
|
T-cell acute lymphoblastic leukemia |
missense_variant |
2.532% (16/632) |
2 entries |
ENSG00000184634 |
|
chronic lymphocytic leukemia |
conservative_inframe_deletion |
3.575% (70/1958) |
2 entries |
ENSG00000184634 |
|
rectal adenocarcinoma |
sequence_alteration |
4.348% (24/552) |
2 entries |
ENSG00000184634 |
|
diffuse gastric adenocarcinoma |
missense_variant |
6.098% (5/82) |
3 entries |
ENSG00000184634 |
|
T-cell acute lymphoblastic leukemia |
frameshift_variant |
2.532% (16/632) |
1 entry |
ENSG00000184634 |
|
Breast Carcinoma by Gene Expression Profile |
sequence_alteration |
2.588% (33/1275) |
2 entries |
ENSG00000184634 |
|
endometrial stromal sarcoma |
missense_variant |
10.0% (3/30) |
1 entry |
ENSG00000184634 |
|
angiosarcoma |
missense_variant |
4.0% (2/50) |
2 entries |
ENSG00000184634 |
|
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
missense_variant |
1.136% (3/264) |
1 entry |
ENSG00000184634 |
|
female breast carcinoma |
sequence_alteration |
1.882% (8/425) |
2 entries |
ENSG00000184634 |
|
Endometrial Endometrioid Adenocarcinoma |
stop_gained |
6.769% (44/650) |
2 entries |
ENSG00000184634 |
|
thyroid carcinoma |
missense_variant |
4.428% (41/926) |
1 entry |
ENSG00000184634 |
|
lung adenocarcinoma |
stop_gained |
3.743% (95/2538) |
2 entries |
ENSG00000184634 |
|
melanoma |
stop_gained |
11.64% (17/146) |
1 entry |
ENSG00000184634 |
|
Cortisol-Producing Adrenal Cortex Adenoma |
missense_variant |
1.613% (2/124) |
2 entries |
ENSG00000184634 |
|
colon adenocarcinoma |
missense_variant |
5.594% (72/1287) |
7 entries |
ENSG00000184634 |
|
gastric adenocarcinoma |
missense_variant |
4.625% (37/800) |
4 entries |
ENSG00000184634 |
|
acute lymphoblastic leukemia |
missense_variant |
1.42% (5/352) |
3 entries |
ENSG00000184634 |
|
smooth muscle tumor |
sequence_alteration |
13.33% (6/45) |
4 entries |
ENSG00000184634 |
|
cecum adenocarcinoma |
missense_variant |
6.415% (17/265) |
3 entries |
ENSG00000184634 |
|
metaplastic breast carcinoma |
missense_variant |
1.709% (2/117) |
2 entries |
ENSG00000184634 |
|
squamous cell lung carcinoma |
stop_gained |
1.717% (16/932) |
1 entry |
ENSG00000184634 |
|
basal cell carcinoma |
missense_variant |
13.24% (9/68) |
2 entries |
ENSG00000184634 |
|
prostate adenocarcinoma |
sequence_alteration |
1.408% (35/2486) |
1 entry |
ENSG00000184634 |
|
breast ductal adenocarcinoma |
conservative_inframe_deletion |
2.232% (41/1837) |
1 entry |
ENSG00000184634 |
|
Endometrial Endometrioid Adenocarcinoma |
sequence_alteration |
6.769% (44/650) |
1 entry |
ENSG00000184634 |
|
Uterine Carcinosarcoma |
missense_variant |
2.703% (4/148) |
1 entry |
ENSG00000184634 |
|
head and neck squamous cell carcinoma |
missense_variant |
0.4769% (3/629) |
1 entry |
ENSG00000184634 |
|
pharyngeal squamous cell carcinoma |
missense_variant |
1.399% (2/143) |
2 entries |
ENSG00000184634 |
|
prostate carcinoma |
missense_variant |
3.03% (17/561) |
3 entries |
ENSG00000184634 |
|
rectal adenocarcinoma |
missense_variant |
4.348% (24/552) |
3 entries |
ENSG00000184634 |
|
lung adenocarcinoma |
missense_variant |
3.743% (95/2538) |
6 entries |
ENSG00000184634 |
|
Gallbladder Adenocarcinoma |
missense_variant |
1.818% (3/165) |
1 entry |
ENSG00000184634 |
|
urothelial carcinoma |
missense_variant |
6.977% (6/86) |
1 entry |
ENSG00000184634 |
|
pancreatic ductal adenocarcinoma |
sequence_alteration |
1.688% (29/1718) |
1 entry |
ENSG00000184634 |
|
urothelial carcinoma |
sequence_alteration |
6.977% (6/86) |
1 entry |
ENSG00000184634 |
|
smooth muscle tumor |
missense_variant |
13.33% (6/45) |
2 entries |
ENSG00000184634 |
|
leiomyoma |
translational_product_function_variant |
51.81% (1915/3696) |
1 entry |
ENSG00000184634 |
|
colon adenocarcinoma |
amino_acid_insertion |
5.594% (72/1287) |
3 entries |
ENSG00000184634 |
|
small cell lung carcinoma |
missense_variant |
3.386% (15/443) |
4 entries |
ENSG00000184634 |
|
Breast Carcinoma by Gene Expression Profile |
frameshift_variant |
2.588% (33/1275) |
2 entries |
ENSG00000184634 |
|
breast adenosis |
missense_variant |
16.67% (2/12) |
1 entry |
ENSG00000184634 |
|
female breast carcinoma |
missense_variant |
1.882% (8/425) |
2 entries |
ENSG00000184634 |
|
Merkel cell skin cancer |
missense_variant |
5.263% (5/95) |
3 entries |
ENSG00000184634 |
|
kidney Wilms tumor |
sequence_alteration |
0.9091% (3/330) |
3 entries |
ENSG00000184634 |
|
chronic lymphocytic leukemia |
sequence_alteration |
3.575% (70/1958) |
6 entries |
ENSG00000184634 |
|
colorectal adenocarcinoma |
stop_gained |
3.268% (73/2234) |
1 entry |
ENSG00000184634 |
|
Breast Carcinoma by Gene Expression Profile |
missense_variant |
2.588% (33/1275) |
3 entries |
ENSG00000184634 |
|
T-cell acute lymphoblastic leukemia |
amino_acid_insertion |
2.532% (16/632) |
2 entries |
ENSG00000184634 |
|
thyroid carcinoma |
sequence_alteration |
4.428% (41/926) |
1 entry |
ENSG00000184634 |
|
glioma |
missense_variant |
0.8333% (5/600) |
1 entry |
ENSG00000184634 |
|
colorectal adenocarcinoma |
missense_variant |
3.268% (73/2234) |
4 entries |
ENSG00000184634 |
|
squamous cell lung carcinoma |
missense_variant |
1.717% (16/932) |
1 entry |
ENSG00000184634 |
|
non-small cell lung carcinoma |
missense_variant |
3.81% (4/105) |
2 entries |
ENSG00000184634 |
|
melanoma |
conservative_inframe_deletion |
11.64% (17/146) |
1 entry |
ENSG00000184634 |
|
cecum adenocarcinoma |
conservative_inframe_deletion |
6.415% (17/265) |
2 entries |
ENSG00000184634 |
|
colorectal adenocarcinoma |
sequence_alteration |
3.268% (73/2234) |
3 entries |
ENSG00000184634 |
|
hemangioblastoma |
sequence_alteration |
11.43% (4/35) |
1 entry |
ENSG00000184634 |
|
breast ductal adenocarcinoma |
sequence_alteration |
2.232% (41/1837) |
2 entries |
ENSG00000184634 |
|
melanoma |
missense_variant |
11.64% (17/146) |
3 entries |
ENSG00000184634 |
|
skin melanoma |
missense_variant |
3.27% (38/1162) |
4 entries |
ENSG00000184634 |
|
esophageal adenocarcinoma |
missense_variant |
0.5474% (3/548) |
2 entries |
ENSG00000184634 |
|
leiomyosarcoma |
conservative_inframe_deletion |
8.062% (57/707) |
6 entries |
ENSG00000184634 |
|
pancreatic neuroendocrine tumor |
missense_variant |
2.542% (6/236) |
1 entry |
ENSG00000184634 |
|
Mixed Lobular and Ductal Breast Carcinoma |
missense_variant |
3.896% (3/77) |
1 entry |
ENSG00000184634 |
|
oral squamous cell carcinoma |
missense_variant |
2.662% (7/263) |
3 entries |
ENSG00000184634 |
|
oral squamous cell carcinoma |
amino_acid_insertion |
2.662% (7/263) |
1 entry |
ENSG00000184634 |
|
squamous cell lung carcinoma |
sequence_alteration |
1.717% (16/932) |
1 entry |
ENSG00000184634 |
|
breast carcinoma |
amino_acid_insertion |
2.267% (38/1676) |
1 entry |
ENSG00000184634 |
|
prostate carcinoma |
sequence_alteration |
3.03% (17/561) |
1 entry |
ENSG00000184634 |
|
ovarian serous adenocarcinoma |
missense_variant |
0.5371% (5/931) |
2 entries |
ENSG00000184634 |
|
Fibroadenoma |
amino_acid_insertion |
53.44% (334/625) |
1 entry |
ENSG00000184634 |
|
bladder transitional cell carcinoma |
missense_variant |
2.381% (11/462) |
1 entry |
ENSG00000184634 |
|
brain glioblastoma |
missense_variant |
1.896% (23/1213) |
6 entries |
ENSG00000184634 |
|
pancreatic ductal adenocarcinoma |
missense_variant |
1.688% (29/1718) |
2 entries |
ENSG00000184634 |
|
bladder transitional cell carcinoma |
sequence_alteration |
2.381% (11/462) |
2 entries |
ENSG00000184634 |
|
bronchoalveolar adenocarcinoma |
missense_variant |
18.18% (4/22) |
2 entries |
ENSG00000184634 |
|
laryngeal squamous cell carcinoma |
missense_variant |
4.878% (2/41) |
1 entry |
ENSG00000184634 |
|
colon adenocarcinoma |
sequence_alteration |
5.594% (72/1287) |
4 entries |
ENSG00000184634 |
|
acute lymphoblastic leukemia |
amino_acid_insertion |
1.42% (5/352) |
1 entry |
ENSG00000184634 |
|
endometrial stromal sarcoma |
stop_gained |
10.0% (3/30) |
1 entry |
ENSG00000184634 |
|
Duodenal Adenocarcinoma |
sequence_alteration |
5.882% (1/17) |
1 entry |
ENSG00000184634 |
|
alveolar rhabdomyosarcoma |
missense_variant |
1.538% (1/65) |
1 entry |
ENSG00000184634 |
|
cecum adenocarcinoma |
amino_acid_insertion |
6.415% (17/265) |
1 entry |
ENSG00000184634 |
|
pancreatic neuroendocrine tumor |
stop_gained |
2.542% (6/236) |
1 entry |
ENSG00000184634 |
|
renal cell carcinoma |
stop_gained |
1.471% (1/68) |
1 entry |
ENSG00000184634 |
|
follicular thyroid carcinoma |
missense_variant |
1.429% (1/70) |
1 entry |
ENSG00000184634 |
|
anaplastic oligodendroglioma |
missense_variant |
1.163% (1/86) |
1 entry |
ENSG00000184634 |
|
endometrial carcinoma |
missense_variant |
3.448% (1/29) |
1 entry |
ENSG00000184634 |
|
hemangioblastoma |
missense_variant |
11.43% (4/35) |
1 entry |
ENSG00000184634 |
|
Duodenal Adenocarcinoma |
missense_variant |
5.882% (1/17) |
1 entry |
ENSG00000184634 |
|
gliosarcoma |
missense_variant |
9.091% (1/11) |
1 entry |
ENSG00000184634 |
|
brain glioblastoma |
frameshift_variant |
1.896% (23/1213) |
1 entry |
ENSG00000184634 |
|
esophageal squamous cell carcinoma |
stop_gained |
1.46% (10/685) |
1 entry |
ENSG00000184634 |
|
osteosarcoma |
missense_variant |
1.948% (3/154) |
1 entry |
ENSG00000184634 |
|
mucosal melanoma |
missense_variant |
1.429% (1/70) |
1 entry |
ENSG00000184634 |
|
PEComa |
sequence_alteration |
13.33% (2/15) |
1 entry |
ENSG00000184634 |
|
synovial sarcoma |
missense_variant |
2.326% (1/43) |
1 entry |
ENSG00000184634 |
|
diffuse large B-cell lymphoma |
sequence_alteration |
1.081% (4/370) |
1 entry |
ENSG00000184634 |
|
adrenal cortex carcinoma |
conservative_inframe_deletion |
2.632% (7/266) |
1 entry |
ENSG00000184634 |
|
Granular Cell Tumor |
missense_variant |
50.0% (1/2) |
1 entry |
ENSG00000184634 |
|
Lung Sarcomatoid Carcinoma |
sequence_alteration |
7.143% (1/14) |
1 entry |
ENSG00000184634 |
|
Mediastinal Malignant Germ Cell Tumor |
missense_variant |
6.667% (1/15) |
1 entry |
ENSG00000184634 |
|
Mantle cell lymphoma |
stop_gained |
1.887% (1/53) |
1 entry |
ENSG00000184634 |
|
rectal adenocarcinoma |
conservative_inframe_deletion |
4.348% (24/552) |
1 entry |
ENSG00000184634 |
|
osteosarcoma |
sequence_alteration |
1.948% (3/154) |
1 entry |
ENSG00000184634 |
|
pancreatic ductal adenocarcinoma |
frameshift_variant |
1.688% (29/1718) |
1 entry |
ENSG00000184634 |
|
rectal adenocarcinoma |
stop_gained |
4.348% (24/552) |
1 entry |
ENSG00000184634 |
|
lobular breast carcinoma |
sequence_alteration |
2.5% (7/280) |
1 entry |
ENSG00000184634 |
|
anaplastic oligodendroglioma |
sequence_alteration |
1.163% (1/86) |
1 entry |
ENSG00000184634 |
|
HER2 Positive Breast Carcinoma |
missense_variant |
2.632% (3/114) |
1 entry |
ENSG00000184634 |
|
leiomyosarcoma |
frameshift_variant |
8.062% (57/707) |
1 entry |
ENSG00000184634 |
|
bladder transitional cell carcinoma |
amino_acid_insertion |
2.381% (11/462) |
1 entry |
ENSG00000184634 |
|
Pleural Mesothelioma |
frameshift_variant |
0.7042% (1/142) |
1 entry |
ENSG00000184634 |
|
rectal adenocarcinoma |
amino_acid_insertion |
4.348% (24/552) |
1 entry |
ENSG00000184634 |
|
cecum adenocarcinoma |
frameshift_variant |
6.415% (17/265) |
1 entry |
ENSG00000184634 |
|
Dermatofibrosarcoma protuberans |
frameshift_variant |
25.0% (1/4) |
1 entry |
ENSG00000184634 |
|
papillary thyroid carcinoma |
amino_acid_insertion |
0.1957% (1/511) |
1 entry |
ENSG00000184634 |
|
lung carcinoid tumor |
missense_variant |
3.704% (1/27) |
1 entry |
ENSG00000184634 |
|
smooth muscle tumor |
conservative_inframe_deletion |
13.33% (6/45) |
1 entry |
ENSG00000184634 |
|
colon adenocarcinoma |
stop_gained |
5.594% (72/1287) |
1 entry |
ENSG00000184634 |
|
endometrium adenocarcinoma |
conservative_inframe_deletion |
3.704% (1/27) |
1 entry |
ENSG00000184634 |
|
Pleural Mesothelioma |
sequence_alteration |
0.7042% (1/142) |
1 entry |
ENSG00000184634 |
|
PEComa |
missense_variant |
13.33% (2/15) |
1 entry |
ENSG00000184634 |
|
bladder transitional cell carcinoma |
stop_gained |
2.381% (11/462) |
1 entry |
ENSG00000184634 |
|
Appendix Goblet Cell Carcinoid |
missense_variant |
12.5% (1/8) |
1 entry |
ENSG00000184634 |
|
angioimmunoblastic T-cell lymphoma |
missense_variant |
4.545% (1/22) |
1 entry |
ENSG00000184634 |
|
medulloblastoma |
missense_variant |
4.167% (1/24) |
1 entry |
ENSG00000184634 |
|
diffuse large B-cell lymphoma |
amino_acid_insertion |
1.081% (4/370) |
1 entry |
ENSG00000184634 |
|
Endometrial Endometrioid Adenocarcinoma |
frameshift_variant |
6.769% (44/650) |
1 entry |
ENSG00000184634 |
|
testicular seminoma |
missense_variant |
1.282% (1/78) |
1 entry |
ENSG00000184634 |
|
small intestinal adenocarcinoma |
missense_variant |
4.762% (1/21) |
1 entry |
ENSG00000184634 |
|
B-cell acute lymphoblastic leukemia |
frameshift_variant |
0.9009% (1/111) |
1 entry |
ENSG00000184634 |
|
kidney Wilms tumor |
conservative_inframe_deletion |
0.9091% (3/330) |
1 entry |
ENSG00000184634 |
|
Parotid Gland Adenoid Cystic Carcinoma |
missense_variant |
7.143% (1/14) |
1 entry |
ENSG00000184634 |
|
Uterine Carcinosarcoma |
sequence_alteration |
2.703% (4/148) |
1 entry |
ENSG00000184634 |
|
Mediastinal Malignant Germ Cell Tumor |
sequence_alteration |
6.667% (1/15) |
1 entry |
ENSG00000184634 |
|
salivary gland carcinoma |
sequence_alteration |
3.03% (1/33) |
1 entry |
ENSG00000184634 |
|
angiosarcoma |
sequence_alteration |
4.0% (2/50) |
1 entry |
ENSG00000184634 |
|
head and neck squamous cell carcinoma |
frameshift_variant |
0.4769% (3/629) |
1 entry |
ENSG00000184634 |
|
lobular breast carcinoma |
stop_gained |
2.5% (7/280) |
1 entry |
ENSG00000184634 |
|
small cell carcinoma |
missense_variant |
33.33% (1/3) |
1 entry |
ENSG00000184634 |
|
Testicular Choriocarcinoma |
missense_variant |
20.0% (1/5) |
1 entry |
ENSG00000184634 |
|
lung adenocarcinoma |
stop_lost |
3.743% (95/2538) |
1 entry |
ENSG00000184634 |
|
basal cell carcinoma |
sequence_alteration |
13.24% (9/68) |
1 entry |
ENSG00000184634 |
|
bronchoalveolar adenocarcinoma |
stop_gained |
18.18% (4/22) |
1 entry |
ENSG00000184634 |
|
Thymic Squamous Cell Carcinoma |
conservative_inframe_deletion |
5.556% (1/18) |
1 entry |
ENSG00000184634 |
|
hemangioblastoma |
conservative_inframe_deletion |
11.43% (4/35) |
1 entry |
ENSG00000184634 |
|
osteosarcoma |
conservative_inframe_deletion |
1.948% (3/154) |
1 entry |
ENSG00000184634 |
|
Placental Choriocarcinoma |
conservative_inframe_deletion |
20.0% (1/5) |
1 entry |
ENSG00000184634 |
|
malignant peripheral nerve sheath tumor |
frameshift_variant |
7.143% (1/14) |
1 entry |
ENSG00000184634 |
|
follicular dendritic cell sarcoma |
frameshift_variant |
25.0% (1/4) |
1 entry |
ENSG00000184634 |
|
carcinoid tumor |
frameshift_variant |
16.67% (1/6) |
1 entry |
ENSG00000184634 |
|
pulmonary blastoma |
missense_variant |
4.167% (1/24) |
1 entry |
ENSG00000184634 |
|
small cell lung carcinoma |
stop_gained |
3.386% (15/443) |
1 entry |
ENSG00000184634 |
|
hemangioblastoma |
amino_acid_insertion |
11.43% (4/35) |
1 entry |
ENSG00000184634 |
|
pancreatic ductal adenocarcinoma |
conservative_inframe_deletion |
1.688% (29/1718) |
1 entry |
ENSG00000184634 |
|
small cell lung carcinoma |
frameshift_variant |
3.386% (15/443) |
1 entry |
ENSG00000184634 |
|
lobular breast carcinoma |
conservative_inframe_deletion |
2.5% (7/280) |
1 entry |
ENSG00000184634 |
|
marginal zone B-cell lymphoma |
missense_variant |
1.471% (1/68) |
1 entry |
ENSG00000184634 |
|
adrenal cortex carcinoma |
frameshift_variant |
2.632% (7/266) |
1 entry |
ENSG00000184634 |
|
gastric intestinal type adenocarcinoma |
conservative_inframe_deletion |
3.529% (3/85) |
1 entry |
ENSG00000184634 |
|
Endometrial Undifferentiated Carcinoma |
sequence_alteration |
33.33% (1/3) |
1 entry |
ENSG00000184634 |
|
Gastrointestinal stromal tumor |
missense_variant |
0.5952% (1/168) |
1 entry |
ENSG00000184634 |
|
pancreatic ductal adenocarcinoma |
stop_gained |
1.688% (29/1718) |
1 entry |
ENSG00000184634 |
|
Ovarian Granulosa Cell Tumor |
missense_variant |
3.125% (1/32) |
1 entry |
ENSG00000184634 |
|
oral squamous cell carcinoma |
sequence_alteration |
2.662% (7/263) |
1 entry |
ENSG00000184634 |
|
bladder transitional cell carcinoma |
conservative_inframe_deletion |
2.381% (11/462) |
1 entry |
ENSG00000184634 |
|
colon carcinoma |
missense_variant |
12.5% (1/8) |
1 entry |
ENSG00000184634 |
|
Solid Pseudopapillary Neoplasm of the Pancreas |
missense_variant |
4.545% (1/22) |
1 entry |
ENSG00000184634 |
|
anaplastic astrocytoma |
sequence_alteration |
1.515% (2/132) |
1 entry |
ENSG00000184634 |
|
nasopharyngeal squamous cell carcinoma |
conservative_inframe_deletion |
0.6494% (2/308) |
1 entry |
ENSG00000184634 |
|
skin carcinoma |
missense_variant |
2.885% (3/104) |
1 entry |
ENSG00000184634 |
|
Cervical Adenosquamous Carcinoma |
stop_gained |
20.0% (1/5) |
1 entry |
ENSG00000184634 |
|
head and neck squamous cell carcinoma |
sequence_alteration |
0.4769% (3/629) |
1 entry |
ENSG00000184634 |
|
brain glioblastoma |
conservative_inframe_deletion |
1.896% (23/1213) |
1 entry |
ENSG00000184634 |
|
salivary gland adenoid cystic carcinoma |
missense_variant |
1.587% (1/63) |
1 entry |
ENSG00000184634 |
|
nasal cavity and paranasal sinus carcinoma |
missense_variant |
4.348% (1/23) |
1 entry |
ENSG00000184634 |
|
diffuse large B-cell lymphoma |
frameshift_variant |
1.081% (4/370) |
1 entry |
ENSG00000184634 |
|
PEComa |
frameshift_variant |
13.33% (2/15) |
1 entry |
ENSG00000184634 |
|
salivary gland carcinoma |
missense_variant |
3.03% (1/33) |
1 entry |
ENSG00000184634 |
|
neoplasm of mature B-cells |
sequence_alteration |
3.279% (2/61) |
1 entry |
ENSG00000184634 |
|
breast carcinoma |
conservative_inframe_deletion |
2.267% (38/1676) |
1 entry |
ENSG00000184634 |
|
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
sequence_alteration |
1.136% (3/264) |
1 entry |
ENSG00000184634 |
|
Ovarian Small Cell Carcinoma |
sequence_alteration |
6.667% (1/15) |
1 entry |
ENSG00000184634 |
|
Endometrial Polyp |
sequence_alteration |
0.7752% (1/129) |
1 entry |
ENSG00000184634 |
|
Endometrial Polyp |
missense_variant |
0.7752% (1/129) |
1 entry |